IdyllaTM EGFR Mutation Test, IdyllaTM (ct)EGFR Mutation Assay, IdyllaTM KRAS Mutation Test and IdyllaTM (ct)KRAS Mutation Assay
These products are made under a license from SpeeDx Pty Lts. US Patents 8,394,946 and 8,945,836, and pending US applications and all their respective foreign equivalent, supplied under license of SpeeDx Pty Ltd.
These products are made under a license from SpeeDx Pty Lts. US Patents 9,506,108, 10,273,526, US 9,963,738 and US 10,724,080 and pending US applications and all their respective foreign equivalent, supplied under license of SpeeDx Pty Ltd.
IdyllaTM GeneFusion Assay and IdyllaTM GeneFusion Panel
These products contain SuperScript™ III Reverse Transcriptase and is provided subject to a license under patents or patent applications owned by or licensed to Life Technologies Corporation, which license is limited to the human diagnostic field and research field and specifically excludes applications in forensics (including human identity testing). The SuperScript™ III trademark is owned by Life Technologies Corporation.
Patents US 7,700,339, 8,168,383, 8,481,279, 8,486,645, 8,232,060, 8,288,102, 8,377,642, 9,988,688, 9,523,130, 9,096,855, 10,526,661, 9,364,477, 9,539,254, 10,551,383 and pending US applications and all their respective foreign equivalents under license from Cell Signaling Technology, Inc.
IdyllaTM BRAF Mutation Test and IdyllaTM BRAF Mutation Assay
The MGB Probe contained in this product is covered by one or more of the following US patents and corresponding patents outside the US: 5,801 ,155 and 6,084,102 and is sold under a license from the ELITech Group. The purchase of this product includes a license to use only this amount of product solely for the purchaser's own use solely in the human in vitro diagnostic field (in accordance with applicable FDA and other regulatory requirements) and may not be used for any other commercial use, including without limitation repackaging or resale in any form.
IdyllaTM ThyroidPrint® Assay
This product contains SuperScript™ III Reverse Transcriptase and is provided subject to a license under patents or patent applications owned by or licensed to Life Technologies Corporation, which license is limited to the human diagnostic field and research field and specifically excludes applications in forensics (including human identity testing). The SuperScript™ III trademark is owned by Life Technologies Corporation.
This product is developed by GeneproDX and distributed by Biocartis.
IdyllaTM NRAS-BRAF Mutation Test and IdyllaTM (ct)NRAS-BRAF-EGFR S492R Mutation Assay
These products are made under a license from SpeeDx Pty Lts. US Patents 8,394,946 and 8,945,836, and pending US applications and all their respective foreign equivalent, supplied under license of SpeeDx Pty Ltd.
These products are made under a license from SpeeDx Pty Lts. US Patents 9,506,108, 10,273,526, US 9,963,738 and US 10,724,080 and pending US applications and all their respective foreign equivalent, supplied under license of SpeeDx Pty Ltd.
These products contain Hilyte. "Hilyte™” is a trademark of Anaspec, Inc. Hilyte is licensed pursuant to an agreement with Eurogentec S.A., and these Licensed Probes are sold exclusively for diagnostic purposes.
These products contain QXL. “QXL®” is a registered trademark of Anaspec, Inc. QXL is licensed pursuant to an agreement with Eurogentec S.A., and these Licensed Probes are sold exclusively for diagnostic purposes.
IdyllaTM PIK3CA-AKT1 Mutation Assay
Idylla™ PIK3CA-AKT1 Mutation Assay has been developed in collaboration with LifeArc.
IdyllaTM CP-GEP
This product contains SuperScript™ III Reverse Transcriptase and is provided subject to a license under patents or patent applications owned by or licensed to Life Technologies Corporation, which license is limited to the human diagnostic field and research field and specifically excludes applications in forensics (including human identity testing). The SuperScript™ III trademark is owned by Life Technologies Corporation.
This product is developed by SkylineDx and will be distributed by Biocartis.